HaCaT human keratinocytes express IGF-II, IGFBP-6, and an acid-activated protease with activity against IGFBP-6

American Journal of Physiology - Endocrinology and Metabolism

Volumn 276, Issue 3 39-3, 1999, Pages

  Marinaro, Joe A ^a   Hendrich, Elke C ^a   Leeding, Kerri S ^a   Bach, Leon A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Autocrine growth factor; Binding protein; Cathepsin D; Insulin like growth factor

Indexed keywords

CATHEPSIN D; PROTEINASE; SOMATOMEDIN BINDING PROTEIN 6; SOMATOMEDIN C;

AMINO TERMINAL SEQUENCE; ARTICLE; AUTOCRINE EFFECT; CELL PROLIFERATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

EID: 0032955685     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.1999.276.3.e536     Document Type: Article

References (42)

1. Bach, L. A., S. Hsieh, A. L. Brown, and M. M. Rechler. Recombinant human insulin-like growth factor binding protein-6 inhibits IGF-II-induced differentiation of L6A1 myoblasts. Endocrinology 135: 2168-2176, 1994.
2. Bach, L. A., S. Hsieh, K. Sakano, H. Fujiwara, J. Perdue, and M. Rechler. Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding protein 1-6. J. Biol. Chem. 268: 9246-9254, 1993.
3. Bach, L. A., and M. M. Rechler. Insulin-like growth factor binding proteins. Diabetes Rev. 3: 38-61, 1995.
4. Bach, L. A., N. R. Thotakura, and M. M. Rechler. Human insulin-like growth factor binding protein-6 is O-glycosylated. Biochem. Biophys. Res. Commun. 186: 301-307, 1992.
5. Barbi, G. P., E. Margallo, M. Marglocco, M. Paganuzzi, P. Marroni, B. Costanzi, B. Gatteschi, G. Tanara, B. Spina, and G. Nicolo. Evaluation of cathepsin D as prognostic predictor in breast cancer. Oncology 51: 329-333, 1994.
6. Batch, J. A., F. A. Mercuri, S. R. Edmondson, and G. A. Werther. Localization of messenger ribonucleic acid for insulin-like growth factor-binding proteins in human skin by in situ hybridization. J. Clin. Endocrinol. Metab. 79: 1444-1449, 1994.
7. Boukamp, P., R. T. Petrussevka, D. Breitkreutz, J. Hornung, A. Markham, and N. E. Fusenig. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106: 761-771, 1988.
8. Capony, F., T. Braulke, C. Rougeot, S. Roux, P. Montcourrier, and H. Rochefort. Specific mannose-6-phosphate receptor-independent sorting of pro-cathepsin D in breast cancer cells. Exp. Cell Res. 215: 154-163, 1994.
9. Claussen, A., B. Kubler, M. Wendland, K. Neifer, B. Schmid, J. Zapf, and T. Braulke. Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D. Endocrinology 138: 3797-3803, 1997.
10. Claussen, M., D. Buergisser, A. G. P. Schuller, U. Matzner, and T. Braulke. Regulation of insulin-like growth factor (IGF)-binding protein-6 and mannose 6-phosphate/IGF-II receptor expression in IGF-II-overexpressing NIH 3T3 cells. Mol. Endocrinol. 9: 902-912, 1995.
11. Conover, C. A. Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. Endocrinology 130: 3191-3199, 1992.
12. Conover, C. A., and D. D. De Leon. Acid-activated insulin-like growth factor-binding protein-3 proteolysis in normal and transformed cells. J. Biol. Chem. 269: 7076-7080, 1994.
13. De Leon, D. D., C. Terry, and S. P. Nissley. Direct detection of insulin-like growth factor II (IGF-II) by chemiluminescence without interference by IGF binding proteins. Endocrinology 134: 1960-1963, 1994.
14. Delhanty, P. J., D. J. Hill, S. Shimasaki, and V. K. Han. Insulin-like growth factor binding protein-4, -5 and -6 mRNAs in the human fetus: localization to sites of growth and differentiation? Growth Regul. 3: 8-11, 1993.
15. Jansen, M., F. M. A. van Schaik, H. Van Tol, J. L. Van den Brande, and J. S. Sussenbach. Nucleotide sequences of cDNAs encoding precursors of human insulin-like growth factor II (IGF-II) and an IGF-II variant. FEBS Lett. 179: 243-246, 1985.
16. Jones, J. I., and D. R. Clemmons. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16: 3-34, 1995.
17. Kalsner, I., F. J. Schneider, R. Geyer, H. Ahorn, and I. Maurer-Fogy. Comparison of the carbohydrate moieties of recombinant soluble Fc epsilon receptor (sFc epsilon RII/sCD23) expressed in Saccharomyces cerevisiae and Chinese hamster ovary cells. Different O-glycosylation sites are used by yeast and mammalian cells. Glycoconjugate J. 9: 209-216, 1992.
18. Kato, M., A. Ishizaki, U. Hellman, C. Wernstedt, M. Kyogoku, K. Miyazono, C. Heldin, and K. Funa. A human keratinocyte cell line produces two autocrine growth inhibitors, transforming growth factor-β and insulin-like growth factor binding protein-6, in a calcium-and cell density-dependent manner. J. Biol. Chem. 270: 12373-12379, 1995.
19. Kawada, A., K. Hara, E. Kominami, M. Hiruma, M. Akiyama, A. Ishibashi, H. Abe, E. Ichikawa, Y. Nakamura, S. Watanabe, T. Yamamoto, T. Umeda, and K. Nishioka. Expression of cathepsin D and B in invasion and metastasis of squamous cell carcinoma. Br. J. Dermatol. 137: 361-366, 1997.
20. Kawada, A., K. Hara, E. Kominami, T. Kobayashi, M. Hiruma, and A. Ishibashi. Cathepsin B and D expression in squamous cell carcinoma. Br. J. Dermatol. 135: 905-910, 1996.
21. Kiefer, M., C. Schmid, M. Waldvogel, I. Schlapfer, E. Futo, F. Massiarz, K. Green, P. Barr, and J. Zapf. Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast. J. Biol. Chem. 267: 12692-12699, 1992.
22. Liu, J. P., J. Baker, A. S. Perkins, E. J. Robertson, and A. Efstratiadis. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75: 59-72, 1993.
23. Martin, J., K. Willetts, and R. Baxter. Purification and properties of a novel insulin-like growth factor-II binding protein from transformed human fibroblasts. J. Biol. Chem. 265: 4124-4130, 1990.
24. Martin, J. L., and R. C. Baxter. Insulin-like growth factor-binding protein from human plasma: purification and characterization. J. Biol. Chem. 261: 8754-8760, 1986.
25. Murashita, M. M., V. C. Russo, S. R. Edmondson, C. J. Wraight, and G. A. Werther. Identification of insulin-like growth factor binding proteins from cultured human epidermal keratinocytes. J. Cell Physiol. 163: 339-345, 1995.
26. Nam, T. J., W. H. Busby, Jr., and D. R. Clemmons. Human fibroblasts secrete a serine protease that cleaves insulin-like growth factor-binding protein-5. Endocrinology 135: 1385-1391, 1994.
27. Neumann, G. M., J. M. Marinaro, and L. A. Bach. Identification of O-glycosylation sites and partial characterization of carbohydrate structure and disulfide linkages of human insulin-like growth factor binding protein 6. Biochemistry 37: 6572-6585, 1998.
28. Poole, A. R., and J. S. Mort. Biochemical and immunological studies of lysosomal and related proteinases in health and disease. J. Histochem. Cytochem. 29: 494-500, 1981.
29. Rajah, R., A. Bhala, S. E. Nunn, D. M. Peehl, and P. Cohen. 7S nerve growth factor is an insulin-like growth factor-binding protein protease. Endocrinology 137: 2676-2682, 1996.
30. Richo, G. R., and G. E. Conner. Proteolytic Activation of Human Procathepsin D. New York: Plenum, 1991.
31. Richo, G. R., and G. E. Conner. Structural requirements of procathepsin D activation and maturation. J. Biol. Chem. 269: 14806-14812, 1994.
32. Rochefort, H., F. Capony, and M. Garcia. Cathepsin D: a protease involved in breast cancer metastasis. Cancer Metastasis Rev. 9: 321-331, 1990.
33. Rogler, C. E., D. Yang, L. Rossetti, J. Donohoe, E. Alt, C. J. Chang, R. Rosenfeld, K. Neely, and R. Hintz. Altered body composition and increased frequency of diverse malignancies in insulin-like growth factor-II transgenic mice. J. Biol. Chem. 269: 13779-13784, 1994.
34. Schmid, C., I. Sclapfer, A. Keller, M. Waldvogel, E. Froesch, and J. Zapf. Effects of insulin-like growth factor (IGF) binding proteins (BPs)-3 and -6 on DNA synthesis of rat osteoblasts: further evidence for a role of auto-/paracrine IGF I but not IGF II in stimulating osteoblast growth. Biochem. Biophys. Res. Commun. 212: 242-248, 1995.
35. Shimasaki, S., L. Gao, M. Shimonaka, and N. Ling. Isolation and molecular cloning of insulin-like growth factor-binding protein-6. Mol. Endocrinol. 5: 938-948, 1991.
36. Steenbergh, P. H., A. M. C. B. Koonen-Reemst, C. B. J. M. Cleutjens, and J. S. Sussenbach. Complete nucleotide sequence of the high molecular weight human IGF-I mRNA. Biochem. Biophys. Res. Commun. 175: 507-514, 1991.
37. Suikkari, A.-M., and R. C. Baxter. Insulin-like growth factor (IGF) binding protein-3 in pregnancy serum binds native IGF-I but not iodo-IGF-I. J. Clin. Endocrinol. Metab. 73: 1377-1379, 1991.
38. Tavakkol, A., J. T. Elder, C. E. M. Griffiths, K. D. Cooper, H. Talwar, G. J. Fisher, K. M. Keane, S. K. Foltin, and J. J. Voorhees. Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. J. Invest. Dermatol. 99: 343-349, 1992.
39. Toretsky, J. A., and L. J. Helman. Involvement of IGF-II in human cancer. J. Endocrinol. 149: 367-372, 1996.
40. Ward, A., P. Bates, R. Fisher, L. Richardson, and C. F. Graham. Disproportionate growth in mice with Igf-2 transgenes. Proc. Natl. Acad. Sci. USA 91: 10365-10369, 1994.
41. Wraight, C. J., M. M. Murashita, V. C. Russo, and G. A. Werther. A keratinocyte cell line synthesizes a predominant insulin-like growth factor-binding protein (IGFBP-3) that modulates insulin-like growth factor-I action. J. Invest. Dermatol. 103: 627-631, 1994.
42. Xu, S., P. Savage, J. Burton, J. Sansom, and J. Holly. Proteolysis of insulin-like growth factor-binding protein-3 by human skin keratinocytes in culture in comparison to that in skin interstitial fluid: the role and regulation of components of the plasmin system. J. Clin. Endocrinol. Metab. 82: 1863-1868, 1997.